my account  log out
 

CTLA4[Biotinylated]:B7-2 Inhibitor Screening Assay Kit

Create: 12/17/2018
Expired Date:never
Category: Diagnostic equipment [Health&Medical&Pharmaceutical]
Message:B7-2 (CD86) signaling through CTLA4(CD152) has been shown to inhibit T cell activation. This co-inhibitory pathway can be overactive in many tumors, enabling cancers to escape the host"s immune system. CTLA4-blocking antibodies, including Ipilimumab (Yervoy) and Tremelimumab, have shown clinical efficacy in treating cancer. https://www.creativebiomart.net/ctla4biotinylatedb7-2-inhibitor-screening-assay-kit-465598.htm
City:[US] 
Location:
 
Aug 25 2019Recombinant Human FGF2, None tagged467
Aug 25 2019Recombinant Human PVRL2, None tagged481
Aug 25 2019Recombinant Human PF4, None tagged496
Aug 25 2019Recombinant Human CXADR, Fc-His tagged531
Aug 25 2019Recombinant Mouse Cxadr, Fc-His tagged517
Aug 25 2019Recombinant Human CX3CL1, His tagged514
Aug 25 2019Recombinant Human CST5, His tagged472
Aug 25 2019Recombinant Human CPE, Fc tagged472
Aug 25 2019Recombinant Human Met, Fc-His tagged501
Aug 25 2019Recombinant Human CEACAM1, His tagged493

return back

Copyright © toextrade Inc. All rights reserved. Contact us